Epidemiology and prognosis of T-cell lymphoma

T-Cell Lymphomas

Volumn , Issue , 2013, Pages 25-39

  Wang, Sophia S ^a   Vose, Julie M ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84938792449     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-62703-170-7_2     Document Type: Chapter

References (46)

1. Au WY, Lo J. HTLV-1-related lymphoma in Hong Kong Chinese. Am J Hematol. 2005;78:80-1.
2. Naresh KN, Srinivas V, Soman CS. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classi fi cations. Ann Oncol. 2000;11:63-7.
3. Ng CS, Chan J, Lo S, Poon Y. Immunophenotypic analysis of non-Hodgkin's lymphomas in Chinese. A study of 75 cases in Hong Kong. Pathology. 1986; 18:419-25.
4. Kadin ME, Berard CW, Nanba K, Wakasa H. Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States-Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol. 1983;14:745-72.
5. Carreon JD, Morton LM, Devesa SS, Clarke CA, Gomez SL, Glaser SL, et al. Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004. Cancer Causes Control. 2008;19:1171-81.
6. Goldin LR, Landgren O, McMaster ML, Gridley G, Hemminki K, Li X, et al. Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev. 2005;14:2402-6.
7. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in fi rst-degree relatives of cancer probands. J Natl Cancer Inst. 1994;86:1600-8.
8. Wang SS, Slager SL, Brennan P, Holly EA, De SS, Bernstein L, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;109:3479-88.
9. Friedman DL, Kadan-Lottick NS, Whitton J, Mertens AC, Yasui Y, Liu Y, et al. Increased risk of cancer among siblings of long-term childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 2005;14:1922-7.
10. Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from populationbased and clinical cohorts. Arch Dermatol. 2007;143: 45-50.
11. Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y. The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis. 2001;27:750-6.
12. Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, Cottone M, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001;358:356-61.
13. Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI. Risk of malignancy in patients with celiac disease. Am J Med. 2003;115:191-5.
14. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med. 2003;163:1566-72.
15. Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002; 123:1428-35.
16. Ekstrom SK, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111:4029-38.
17. Vajdic CM, Falster MO, de Sanjose S, Martinez-Maza O, Becker N, Bracci PM, et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res. 2009;69:6482-9.
18. Mueller N. Overview of the epidemiology of malignancy in immune de fi ciency. J Acquir Immune De fi c Syndr. 1999;21:S5-10.
19. Manns A, Cleghorn FR, Falk RT, Hanchard B, Jaffe ES, Bartholomew C, et al. Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago. The HTLV Lymphoma Study Group. Lancet. 1993;342:1447-50.
20. Mortreux F, Gabet AS, Wattel E. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia. 2003;17:26-38.
21. Siemiatycki J, Richardson L, Boffetta P. Occupation. In: Schottenfeld D, Fraumeni JF, editors. Cancer Epidemiology and Prevention. New York: Oxford University Press; 2006. p. 322-54.
22. Boffetta P, de Vocht F. Occupation and the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:369-72.
23. International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans: Dry cleaning, some chlorinated solvents and other industrial chemicals. Lyon, France: International Agency for Research on Cancer;1995.
24. Engel LS, Lan Q, Rothman N. Polychlorinated biphenyls and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:373-6.
25. Colt JS, Severson RK, Lubin J, Rothman N, Camann D, Davis S, et al. Organochlorines in carpet dust and non-Hodgkin lymphoma. Epidemiology. 2005;16:516-25.
26. Colt JS, Davis S, Severson RK, Lynch CF, Cozen W, Camann D, et al. Residential insecticide use and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev. 2006;15:251-7.
27. Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev. 2005;14:925-33.
28. Besson H, Brennan P, Becker N, Nieters A, De SS, Font R, et al. Tobacco smoking, alcohol drinking and non-Hodgkin's lymphoma: European multicenter casecontrol study (Epilymph). Int J Cancer. 2006;119:901-8.
29. Morton LM, Zheng T, Holford TR, Holly EA, Chiu BC, Costantini AS, et al. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol. 2005;6:469-76.
30. Gaziano JM, Gaziano TA, Glynn RJ, Sesso HD, Ajani UA, Stampfer MJ, et al. Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol. 2000; 35:96-105.
31. Chiu BC, Cerhan JR, Gapstur SM, Sellers TA, Zheng W, Lutz CT, et al. Alcohol consumption and non-Hodgkin lymphoma in a cohort of older women. Br J Cancer. 1999;80:1476-82.
32. Lim U, Morton LM, Subar AF, Baris D, Stolzenberg-Solomon R, Leitzmann M, et al. Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol. 2007;166:697-708.
33. Willett EV, Morton LM, Hartge P, Becker N, Bernstein L, Boffetta P, et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer. 2008;122:2062-70.
34. Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, Zheng T, et al. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer. 2008;122:144-54.
35. Zhang Y, Sanjose SD, Bracci PM, Morton LM, Wang R, Brennan P, et al. Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol. 2008;167:1321-31.
36. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol. 2006; 7:27-38.
37. Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM, et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol. 2010;71(3):267-76.
38. Rudiger T, Weisenburger DD, Anderson JR, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classi fi cation Project. Ann Oncol. 2002;13:140-9.
39. Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspeci fi ed (PTCL-U): a new prognostic model from a retrospective multicenter clinical study. Blood. 2004;103:2474-9.
40. Vose JM, Armitage JO, Weisenburger DD. International peripheral T-cell lymphoma study: pathology fi ndings and clinical outcomes. J Clin Oncol. 2008;26:4124-30.
41. Siegert W, Nerl C, Agthe A, et al. Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory fi ndings at presentation: the Kiel Lymphoma Study Group. Ann Oncol. 1995;6:659-64.
42. Weisenburger DD, Gordon BG, Vose JM, et al. Occurrence of the t(2;5)(p23p35) in non-Hodgkin's lymphoma. Blood. 1996;87:3860-8.
43. Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/ Natural Killer Cell Lymphomas: de fi nitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103-11.
44. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunphenotype, and treatment outcome of 113 patients. J Clin Oncol. 1998; 16:70-7.
45. Shimoyama M. Diagnostic criteria and classi fi cation of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-1987). Br J Haematol. 1991;79:428-37.
46. Chen YC, Wang CH, Su IJ, et al. Infection of human T-cell leukemia virus type I and development of human T-cell leukemia lymphoma in patients with hematologic neoplasms: a possible linkage to blood transfusion. Blood. 1989;74:388-94.